On Nov. 28, 2018, the U.S. Food & Drug Administration (FDA) issued a press release stating that alemtuzumab, a multiple sclerosis drug found in the brand names Lemtrada, Genzyme and Campath, had been linked to “serious cases of stroke and tears in the lining of arteries in the head and neck,” which could lead to “permanent disability and even death.”
Free Confidential Lawsuit Evaluation: If you or a loved one has been harmed by the side effects of Lemtrada, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What is Lemtrada?
Approved by the FDA in 2014, Lemtrada is used to treat relapsing forms of multiple sclerosis. The drug works by binding to and killing immune cells that attack myelin; it is believed that the immune cells which grow back after treatment do not cause nerve damage. Lemtrada is manufactured and marketed by Sanofi-SA.
MS Drugs Must Carry Stroke Warning: FDA Health Alert
FDA is henceforth requiring all alemtuzumab-containing medications to carry its most severe “Black-Box Warning”, as well as a warning in the drugs’ Medication Guide, describing the risk of stroke and blood vessel wall tears.
Lemtrada Side Effects
Serious side effects of Lemtrada include:
- Arterial dissection
- Tears in the lining of arteries in the head and neck
Common side effects include:
- Nasal congestion
- Swelling of the nose or throat
- Urinary tract infection
- Upper respiratory tract infection
- Herpes viral infection
- Fungal infection
- Hives or itching
- Thyroid gland disorders
- Pain in the joints, extremities, or back
- Sore mouth or throat
- Tingling feeling
- Abdominal pain
- Flushing of the face, neck, or chest
FDA is advising anyone taking Lemtrada to call a doctor right away if they experience any of the above symptoms of stroke or arterial dissection:
“Healthcare professionals should advise patients at every Lemtrada infusion to seek immediate emergency medical attention if they experience symptoms of ischemic or hemorrhagic stroke or cervicocephalic arterial dissection,” the agency said. “The diagnosis is often complicated because early symptoms such as headache and neck pain are not specific. Promptly evaluate patients who complain of symptoms consistent with these conditions.”
Can I File a Lemtrada Class Action?
Only a qualified attorney can determine whether you are eligible to file a lawsuit against Sanofi, the company that makes Lemtrada, which is why we are currently offering free case evaluations. Please note, however, that we are not pursuing class action status in this litigation. This decision was based on past experience with similar pharmaceutical cases in which our clients’ best interest was served on an individual basis. If you feel you’ve been injured by Lemtrada, contact us today to learn more about your legal rights. You may be entitled to compensation through the filing of a lawsuit and we can help.
Do I Have a Lemtrada Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lemtrada lawsuits. We are handling individual litigation nationwide and currently accepting new stroke and blood vessel wall tear cases in all 50 states.
Free Case Evaluation: Again, if you or a loved one was harmed by Lemtrada, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.